KAPA
Kairos Pharma·AMEX
--
--(--)
--
--(--)
6.22 / 10
Outperform
Analyst sentiment is overwhelmingly bullish (Strong Buy, 100% of 2 opinions), yet fund-flow data reveal a net outflow bias—Medium inflow is positive but Large/Extra-large flows are negative. This divergence between optimistic ratings and liquidity trends supports a wait-and-see position.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-19
InstitutionD. Boral Capital
Times predicted13
Historical Win Rate38.5%
Is money flowing into or out of KAPA?
- KAPA holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.22/10 (Outperform).
